DENTSPLY SIRONA (XRAY) PT Lowered to $13 at Jefferies

Jefferies analyst Michael Sarcone lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $13.00 (from $15.00) while maintaining a Hold rating.

The analyst comments "We affirm Hold rating reflecting the cloudy macro picture + mixed takes from our proprietary US dental survey. Our survey results suggest XRAY's brand still carries weight with docs. However, XRAY following recent mgmt turnover, we await more clarity on new mgmt's strategic plan to stem share loss and grow at market rates. We expect XRAY will need to show signs of growing at market before narrowing its discount val vs peers. We reduce PT to $13 PT."

You May Also Be Interested In

• Three reasons why M&A may pick up: KeyBanc
• Bernstein on U.S. telecom: "Another strong quarter"
• Corteva Inc. (CTVA) PT Lowered to $85 at UBS Amid High Expectations